Your browser is no longer supported. Please, upgrade your browser.
Settings
GNMK GenMark Diagnostics, Inc. daily Stock Chart
GNMK [NASD]
GenMark Diagnostics, Inc.
Index- P/E- EPS (ttm)-0.56 Insider Own4.30% Shs Outstand66.53M Perf Week-8.00%
Market Cap844.02M Forward P/E- EPS next Y-0.12 Insider Trans-12.15% Shs Float55.50M Perf Month-16.86%
Income-33.70M PEG- EPS next Q-0.06 Inst Own99.10% Short Float12.64% Perf Quarter-37.56%
Sales126.90M P/S6.65 EPS this Y9.40% Inst Trans1.52% Short Ratio6.01 Perf Half Y34.92%
Book/sh1.36 P/B8.32 EPS next Y53.80% ROA-26.80% Target Price- Perf Year97.38%
Cash/sh1.78 P/C6.36 EPS next 5Y- ROE-108.60% 52W Range3.36 - 20.88 Perf YTD135.34%
Dividend- P/FCF- EPS past 5Y2.30% ROI-51.50% 52W High-45.45% Beta3.15
Dividend %- Quick Ratio5.20 Sales past 5Y23.50% Gross Margin37.90% 52W Low238.99% ATR0.95
Employees437 Current Ratio5.70 Sales Q/Q117.90% Oper. Margin-21.10% RSI (14)34.85 Volatility6.28% 7.37%
OptionableYes Debt/Eq0.78 EPS Q/Q69.80% Profit Margin-26.50% Rel Volume0.49 Prev Close11.32
ShortableYes LT Debt/Eq0.78 EarningsOct 28 AMC Payout- Avg Volume1.17M Price11.39
Recom1.90 SMA20-14.78% SMA50-16.12% SMA20010.02% Volume549,172 Change0.62%
Aug-05-20Reiterated Needham Buy $19 → $22
Jul-08-20Reiterated Needham Buy $15 → $19
May-05-20Reiterated Needham Buy $11 → $15
Feb-11-20Downgrade Raymond James Outperform → Mkt Perform
Dec-11-19Downgrade JP Morgan Overweight → Neutral
Feb-22-19Reiterated Needham Buy $12
Nov-03-17Reiterated Needham Buy $15 → $11
Nov-03-17Downgrade Raymond James Outperform → Mkt Perform
Sep-18-17Initiated BofA/Merrill Buy $13
Sep-13-17Reiterated Needham Buy $17 → $15
Aug-31-17Resumed BTIG Research Buy $13
Jun-13-17Reiterated Needham Buy $16 → $17
Jan-24-17Reiterated Needham Buy $13 → $15
Feb-24-16Reiterated Needham Buy $13 → $11
Oct-28-15Reiterated Needham Buy $16 → $13
May-06-15Reiterated Canaccord Genuity Buy $16 → $14
Apr-17-15Reiterated Canaccord Genuity Buy $17 → $16
Dec-19-13Initiated Needham Buy $17
Aug-08-13Reiterated Canaccord Genuity Buy $18 → $14
Apr-15-13Reiterated Canaccord Genuity Buy $14 → $18
Oct-14-20 05:20PM  
Oct-09-20 09:59AM  
04:37AM  
Oct-08-20 04:05PM  
04:03PM  
Sep-29-20 10:50AM  
Sep-22-20 07:00AM  
Sep-16-20 10:08AM  
Sep-14-20 04:05PM  
Sep-07-20 01:53PM  
Aug-27-20 12:39PM  
Aug-17-20 08:00AM  
Aug-05-20 02:01AM  
Aug-04-20 05:20PM  
04:05PM  
Jul-29-20 04:05PM  
Jul-24-20 10:15AM  
Jul-22-20 12:22PM  
11:30AM  
Jul-21-20 04:05PM  
04:05PM  
Jul-14-20 06:56AM  
Jul-09-20 09:54PM  
Jul-08-20 04:18PM  
12:07PM  
07:31AM  
04:55AM  
Jul-07-20 04:05PM  
Jun-29-20 07:00AM  
Jun-28-20 04:07PM  
Jun-27-20 01:15PM  
Jun-19-20 12:16PM  
12:00PM  
Jun-16-20 08:00AM  
Jun-12-20 07:55PM  
Jun-10-20 08:35AM  
08:29AM  
May-28-20 10:30AM  
May-27-20 04:05PM  
May-26-20 08:49AM  
May-14-20 11:16AM  
May-11-20 04:01PM  
May-08-20 10:52AM  
May-07-20 10:39AM  
May-06-20 10:59PM  
04:01PM  
May-05-20 08:00AM  
04:01AM  
May-04-20 06:55PM  
04:05PM  
04:03PM  
Apr-27-20 12:31PM  
Apr-24-20 10:50AM  
Apr-23-20 10:01AM  
Apr-22-20 04:05PM  
Apr-20-20 07:54AM  
Apr-08-20 04:26PM  
07:53AM  
02:45AM  
Apr-07-20 04:03PM  
Mar-23-20 07:45PM  
09:31AM  
09:30AM  
Mar-22-20 08:19AM  
Mar-19-20 09:23PM  
Mar-11-20 12:47PM  
10:44AM  
10:18AM  
09:54AM  
09:06AM  
08:26AM  
08:00AM  
Mar-04-20 08:04AM  
Mar-02-20 05:35PM  
04:05PM  
04:03PM  
Feb-25-20 08:35AM  
Feb-24-20 12:30PM  
09:28AM  
Feb-18-20 04:05PM  
Feb-17-20 05:57AM  
Feb-10-20 05:30PM  
05:15PM  
Jan-13-20 07:00AM  
Jan-06-20 07:25AM  
Jan-01-20 12:14PM  
Dec-31-19 07:57AM  
Dec-30-19 04:05PM  
Dec-12-19 09:07PM  
07:38PM  
Nov-13-19 04:05PM  
Nov-07-19 07:22AM  
Nov-06-19 06:45PM  
04:03PM  
Nov-01-19 12:15PM  
Oct-30-19 10:34AM  
Oct-23-19 04:05PM  
Oct-12-19 10:47AM  
Sep-16-19 09:12AM  
Aug-30-19 02:20AM  
GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. It also provides diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, thrombophilia risk test, a warfarin sensitivity test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jensen TylerSVP, Engineering and Tech DevOct 15Sale11.835005,915209,765Oct 16 05:01 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsOct 07Option Exercise12.7658,680748,786319,870Oct 09 06:35 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsOct 07Sale15.0069,7491,046,235250,121Oct 09 06:35 PM
Jensen TylerSVP, Engineering and Tech DevOct 01Sale14.465007,230210,265Oct 02 07:37 PM
Ek John FrederickChief Financial OfficerSep 22Sale13.8241,196569,329181,339Sep 24 05:58 PM
Jensen TylerSVP, Engineering and Tech DevSep 17Sale12.725006,360210,765Sep 18 05:39 PM
Ek John FrederickChief Financial OfficerSep 16Sale12.985,72374,285222,535Sep 18 05:40 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesSep 08Sale11.027708,485137,212Sep 10 06:16 PM
Shaw ChristineVP, Assay DevelopmentSep 08Sale11.022853,14179,714Sep 10 06:14 PM
Mitchell Brian AndrewSVP, OperationsSep 08Sale11.024,00044,080166,651Sep 10 05:45 PM
Jensen TylerSVP, Engineering and Tech DevSep 03Sale12.205006,100211,265Sep 04 05:44 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsAug 27Sale13.1089111,672261,190Aug 28 05:54 PM
Mendel ScottPresident & CEOAug 26Sale15.0250,000751,00081,690Aug 28 05:53 PM
Mitchell Brian AndrewSVP, OperationsAug 26Sale14.743,46451,059170,651Aug 26 06:32 PM
Mitchell Brian AndrewSVP, OperationsAug 25Sale14.142,08329,454174,115Aug 26 06:32 PM
Mendel ScottPresident & CEOAug 25Sale14.144,53264,082489,808Aug 26 06:30 PM
Stier EricSVP & General CounselAug 25Sale14.142,68437,952293,397Aug 26 06:29 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsAug 25Sale14.142,13030,118262,081Aug 26 06:28 PM
Jensen TylerSVP, Engineering and Tech DevAug 25Sale14.141,21117,124211,765Aug 26 06:27 PM
Ek John FrederickChief Financial OfficerAug 25Sale14.141,51521,422228,258Aug 26 06:18 PM
Shaw ChristineVP, Assay DevelopmentAug 25Sale14.143795,35979,999Aug 26 06:17 PM
Gleeson MichaelSVP, Corp. AccountsAug 25Sale14.142,90441,063352,040Aug 26 06:15 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesAug 25Sale14.141,22317,293137,982Aug 26 06:14 PM
Mitchell Brian AndrewSVP, OperationsAug 21Sale15.622,99746,813176,198Aug 24 06:11 PM
Mitchell Brian AndrewSVP, OperationsAug 20Sale15.411,69126,058179,195Aug 24 06:11 PM
Winkler Sarah HollisVP, Human ResourcesAug 20Sale15.4167710,433125,597Aug 24 06:10 PM
Stier EricSVP & General CounselAug 20Sale15.411,60624,748296,081Aug 24 06:08 PM
Jensen TylerSVP, Engineering and Tech DevAug 20Sale15.411,18418,245212,976Aug 24 06:07 PM
Ek John FrederickChief Financial OfficerAug 20Sale15.602,59140,431229,773Aug 24 06:07 PM
Gleeson MichaelSVP, Corp. AccountsAug 20Sale15.411,69126,058354,944Aug 24 07:37 PM
Mendel ScottPresident & CEOAug 20Sale15.412,98846,045494,340Aug 24 06:13 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsAug 20Sale15.411,35320,850264,211Aug 24 06:12 PM
Mitchell Brian AndrewSVP, OperationsAug 19Sale15.5244,881696,553180,886Aug 20 06:15 PM
Mitchell Brian AndrewSVP, OperationsAug 18Sale15.854206,657225,767Aug 20 06:15 PM
Ek John FrederickChief Financial OfficerAug 18Sale15.9828,307452,346232,364Aug 18 06:09 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesAug 17Sale15.3836,570562,447139,205Aug 18 06:15 PM
Ek John FrederickChief Financial OfficerAug 14Sale15.975,07080,968260,671Aug 18 06:09 PM
Mendel ScottPresident & CEOAug 12Sale15.0850,000754,000131,690Aug 14 06:06 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesAug 04Sale18.932083,937175,775Aug 05 07:25 PM
Mitchell Brian AndrewSVP, OperationsAug 04Sale18.9362111,756226,187Aug 05 07:23 PM
Mitchell Brian AndrewSVP, OperationsAug 03Sale17.924,00071,680226,808Aug 03 06:39 PM
Jensen TylerSVP, Engineering and Tech DevJul 28Sale17.302123,668214,160Jul 29 07:09 PM
Harkins Michael JohnSVP, SalesJul 28Sale17.301,05218,200131,074Jul 29 07:03 PM
Winkler Sarah HollisVP, Human ResourcesJul 28Sale17.3073712,750126,274Jul 29 07:01 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesJul 28Sale17.301702,941175,983Jul 29 06:59 PM
Mitchell Brian AndrewSVP, OperationsJul 01Sale14.454,00057,800230,808Jul 02 06:28 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesJun 08Sale9.147807,129176,153Jun 09 05:37 PM
Mitchell Brian AndrewSVP, OperationsJun 01Sale9.724,00038,880234,808Jun 02 06:04 PM
Mitchell Brian AndrewSVP, OperationsMay 28Sale9.522,02119,240238,808Jun 01 05:19 PM
Ek John FrederickChief Financial OfficerMay 28Sale9.521,46013,899265,741Jun 01 05:15 PM
Jensen TylerSVP, Engineering and Tech DevMay 28Sale9.521,16811,119214,372Jun 01 05:13 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffairsMay 28Sale9.522,06619,668265,564Jun 01 05:11 PM
Mendel ScottPresident & CEOMay 28Sale9.523,75135,710447,328Jun 01 05:08 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesMay 28Sale9.521,17911,224176,933Jun 01 05:05 PM
Stier EricSVP & General CounselMay 28Sale9.522,60224,771297,687Jun 01 05:03 PM
Gleeson MichaelSVP, Corp. AccountsMay 28Sale9.522,81526,799433,127Jun 01 04:59 PM
Maderazo Alan BaerVP, Qual, Reg, & Clin AffaiirsMay 19Sale10.461,31913,797267,630May 20 06:12 PM
Mitchell Brian AndrewSVP, OperationsMay 19Sale10.462,13122,290240,829May 20 06:10 PM
Jensen TylerSVP, Engineering and Tech DevMay 19Sale10.461,15412,071215,540May 20 06:06 PM
Mendel ScottPresident & CEOMay 19Sale10.462,80029,288451,079May 20 06:02 PM
Ek John FrederickChief Financial OfficerMay 19Sale10.461,64817,238267,201May 20 06:00 PM
Stier EricSVP & General CounselMay 19Sale10.461,56616,380300,289May 20 05:59 PM
Winkler Sarah HollisVP, Human ResourcesMay 19Sale10.466616,914127,011May 20 05:57 PM
Gleeson MichaelSVP, Corp. AccountsMay 19Sale10.461,64817,238435,942May 20 05:56 PM
Gleeson MichaelSVP, Corp. AccountsMay 07Option Exercise6.4956,816368,736466,308May 08 05:07 PM
Mitchell Brian AndrewSVP, OperationsMay 05Sale13.497039,483242,960May 06 05:29 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesMay 05Sale13.492363,184178,112May 06 05:27 PM
Mitchell Brian AndrewSVP, OperationsMay 01Sale12.444,00049,760243,663May 04 05:10 PM
FAULKNER DARYLDirectorApr 29Option Exercise6.0014,45086,700120,238May 01 06:08 PM
Winkler Sarah HollisVP, Human ResourcesApr 29Sale11.647268,451127,672May 01 06:02 PM
O'Brien Scott AlexanderSVP, Global Mktg & Int'l SalesApr 29Sale11.641681,956178,348May 01 06:05 PM
Jensen TylerSVP, Engineering and Tech DevApr 29Sale11.648309,661216,694May 01 06:06 PM
Harkins Michael JohnSVP, SalesApr 29Sale11.644,12448,003132,126May 01 06:12 PM
Mitchell Brian AndrewSVP, OperationsApr 20Sale8.008,00064,000247,663Apr 21 05:19 PM
Mitchell Brian AndrewSVP, OperationsApr 01Sale3.992,0007,980255,663Apr 03 05:10 PM
OBOYLE KEVIN CDirectorMar 06Buy4.5310,80048,924103,550Mar 09 11:22 AM
Fox JamesDirectorMar 06Buy5.509,00049,50081,085Mar 10 11:44 AM
Kagnoff MichaelDirectorMar 04Buy4.6110,00046,100118,216Mar 05 11:44 AM
Mitchell Brian AndrewSVP, OperationsMar 02Sale3.502,0007,000257,663Mar 03 05:28 PM
Mitchell Brian AndrewSVP, OperationsFeb 27Sale3.511,9876,974259,663Feb 28 05:48 PM
Mendel ScottInterim President & CEOFeb 27Sale3.512,6599,333547,111Feb 28 05:50 PM
Ek John FrederickChief Financial OfficerFeb 27Sale3.511,0403,650268,849Feb 28 05:44 PM
Gleeson MichaelSVP, Corp. AccountsFeb 27Sale3.511,9967,006409,492Feb 28 05:46 PM
Jensen TylerSVP, Engineering and Tech DevFeb 27Sale3.519733,415217,524Feb 28 05:47 PM
Stier EricSVP & General CounselFeb 27Sale3.511,8066,339301,855Feb 28 05:44 PM
Mendel ScottInterim President & CEOFeb 25Sale3.811,4025,342549,770Feb 27 08:54 PM
Mitchell Brian AndrewSVP, OperationsFeb 25Sale3.81232884261,650Feb 27 08:53 PM
Ek John FrederickChief Financial OfficerFeb 25Sale3.815161,966269,889Feb 27 08:50 PM
Stier EricSVP & General CounselFeb 25Sale3.819853,753303,661Feb 27 08:56 PM
Jensen TylerSVP, Engineering and Tech DevFeb 25Sale3.813811,452218,497Feb 27 08:58 PM
Gleeson MichaelSVP, Corp. AccountsFeb 25Sale3.811,0534,012411,488Feb 27 08:59 PM
Gleeson MichaelSVP, Corp. AccountsFeb 20Sale3.809,70136,864326,291Feb 21 05:26 PM
Jensen TylerSVP, Engineering and Tech DevFeb 20Sale3.806,31824,008128,878Feb 21 05:19 PM
Mendel ScottInterim President & CEOFeb 20Sale3.8014,53655,237326,172Feb 21 05:17 PM
Stier EricSVP & General CounselFeb 20Sale3.809,34835,522225,896Feb 21 05:16 PM
Ek John FrederickChief Financial OfficerFeb 20Sale3.808,84833,622165,405Feb 21 05:12 PM
Mitchell Brian AndrewSVP, OperationsFeb 20Sale3.808,15530,989194,382Feb 21 05:09 PM
Winkler Sarah HollisVP, Human ResourcesFeb 20Sale3.803,38712,87153,398Feb 21 05:08 PM
Mitchell Brian AndrewSVP, OperationsFeb 04Sale5.407804,212202,537Feb 05 05:49 PM
Mitchell Brian AndrewSVP, OperationsFeb 03Sale5.412,00010,820203,317Feb 04 06:05 PM